IIVAX | JVMAX | IIVAX / JVMAX | |
Total Expense Ratio | 1.19 | 1.10 | 108% |
Annual Report Gross Expense Ratio | 1.20 | 1.11 | 108% |
Fund Existence | 25 years | 28 years | - |
Gain YTD | 6.070 | 10.189 | 60% |
Front Load | 6% | 5% | 110% |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 634M | 24B | 3% |
Annual Yield % from dividends | 0.74 | 0.55 | 136% |
Returns for 1 year | -7.88 | -5.02 | 157% |
Returns for 3 years | 6.73 | 26.00 | 26% |
Returns for 5 years | 24.22 | 45.23 | 54% |
Returns for 10 years | 9.30 | 46.58 | 20% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HQL | 16.58 | 0.13 | +0.79% |
abrdn Life Sciences Investors | |||
PMBS | 49.98 | 0.19 | +0.38% |
PIMCO Mortgage-Backed Securities Act ETF | |||
LMBS | 50.12 | 0.06 | +0.12% |
First Trust Low Duration Oppos ETF | |||
QCON | 47.92 | N/A | N/A |
American Century Quality Convertible Securities ETF | |||
SVAL | 32.77 | -0.61 | -1.83% |
iShares US Small Cap Value Factor ETF |